ILC Dover Flexible Powder Containment Technologies

Powder containment technology

ILC Dover offers flexible powder containment technologies, eliminating problems associated with the use of traditional metal and glass systems for the pharmaceutical industry.

The company applies flexible solutions to pharmaceutical potent powder containment during processing of bulk compounds and oral solid dosage manufacturing throughout the industry from North America to Europe and Asia.

Pharmaceutical powder containment

As demonstrated by the Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP) principles, both current good manufacturing practices (cGMP) and industrial hygiene (IH) needs can be met by containing the process at the source. By employing flexible containment and using the logic diagrams from the Risk-MaPP process, cleaning is minimised and the operator is protected with this engineering control. As such, processes in multi-product facilities can be safely performed without the risk of cross contamination.

Single-use powder handling systems

The DoverPac® containment system is a highly reliable storage solution for disposable products and single-use powders. Suitable for charging and offloading procedures, the system comprises a tough film liner supported by a durable fabric outer restraint.

The liners are formulated to meet client requirements, delivering high elongation performance for ruggedness and strength. This is complemented by a unique blend of anti-static additives, allowing for the safe and secure containment of pharmaceutical products.

Containment services for bulk compound processing

DoverPac® has gained wide acceptance by the pharmaceutical industry for use during processing of bulk compounds. DoverPac® prevents worker exposure to highly potent compounds and can eliminate the need for protective garments and respirators.

The new EZ Biopac is a contaminant and transfer system designed for easy adjustment to different bulk weights. Achieving a precice and quick fill time, the system keeps the discharge outlet seperate from antistatic polymer material resulting in 2g or less residule in a 5kg bag. In addition, the EZ Biopac has a protective bag to help ensure the support stand and exterior are not contaminated.

Continuous contained powder processing

ILC Dover’s flexible containment technologies allow continuous, contained processing utilizing ArmorFlex™ films developed specifically for the pharmaceutical industry. DoverPac® fabrication techniques are based on over 50 years of experience in life-critical product manufacturing.

Containment for potent compounds

Unlike standard flexible intermediate bulk containers that are not designed specifically for potent compound manufacturing, DoverPac® is designed to assist operators in performing operations without ever opening up the system. And, our ISO: 9001 registration assures product quality and operator safety during pharmaceutical potent powder containment operations.

Flexible containment systems

Flexible containment is a validated process that uses high-quality engineered storage products with a five-year shelf-life. They pass Chilworth incendivity tests, contain antistats to prevent powder sticking to the side of the bag, and have a drug master file (DMF) filed with the FDA.

FDA and EU compliant

ILC’s innovative ArmorFlex containment material is compliant with US Food and Drug Administration (FDA) and EU requirements:

  • Complies with FDA 21 CFR
  • Meets 2002 / 72 / EC requirements
  • Passes USP 661 physicochemical tests for plastics
  • Passes USP 88 class VI (7 day implant)

Flexible containment systems

Flexible containment is a validated process that utilises quality engineered products designed to meet critical requirements for:

  • Five year shelf-life
  • Permanent antistant replaces migrating additives
  • Passes chilworth incendivity tests
  • Drug master file (DMF) filed with FDA

Upgrade existing facilities for potent compound containment

DoverPac® is one of the fastest growing containment solutions in the industry. Our worldwide clients have appreciated the ability to upgrade existing facilities for potent compound containment during processing. This ability to upgrade has allowed our clients to avoid the capital expense of new equipment and / or facility upgrades. And, the fast turn around to facility upgrading for pharmaceutical containment has meant significant decreases in facility start-up times.

Make an enquiry

Press Release

Apollo Continues its Bold Innovation at ILC Dover

The 50th anniversary of the Apollo 11 moon landing draws near and ILC Dover’s ‘Beyond Boundaries™’ culture continues the bold innovation that put humans on the moon and brought them safely back to earth.

Product and Services
White Papers

EZ BioPac Powder Transfer Gets Biologics to Market Faster

This white paper quantifies how one simple change can drastically reduce the time it takes to get biologics manufactured. Getting media and buffer into large-scale, continuous bioprocessing has been burdensome, time-consuming and messy.

ILC Dover LP

One Moonwalker Road


DE 19946-2080

United States of America

+1 302 335 3911 +1 302 335 1320 Podcast on Flexible Containment in Pharmaceutical Industry

ILC Dover Images

Related Projects

ILC Dover Manufacturing Facility

In May 2019, ILC Dover opened a manufacturing facility in Ireland to produce the company’s pharmaceutical and biopharmaceutical product lines. The plant is designed to strengthen the company's single-use powder handling solutions business.

5 June 2019

Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts

In June 2006, Bristol-Myers Squibb made a commitment to construct a new large-scale multiproduct biopharmaceutical manufacturing plant in Devens, Massachusetts, US.

29 May 2016

Eli Lilly Kinsale Pharmaceutical Manufacturing Facility

Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.

29 December 2011

Wacker Chemie Biologics Production Facility

Wacker Chemie inaugurated a new production facility at its Jena site on 8 March 2010. Located approximately 90km south-w

13 April 2010

CoreRX Tampa Facility Expansion

US formulation development company CoreRx Pharmaceuticals (CoreRx), initiated a major expansion of its manufacturing sit

16 July 2009

Patheon Manufacturing Facility Expansion, Toronto

Canadian contract drug maker Patheon, completed the expansion of its Toronto manufacturing facility in April 2009, two m

19 May 2009

SAFC Pharma API Manufacturing Expansion, Republic of Ireland

SAFC Pharma is a multinational operation, part of the US fine chemical company Sigma-Aldrich. SAFC specialises in provid

20 November 2008

Bristol-Myers Squibb – Clinical Supplies Manufacturing

Bristol-Myers Squibb (BMS) has been undergoing much the same rationalisation process as many large pharmaceutical compan

22 April 2008

Abbott Laboratories Biotech Facility, Puerto Rico

Puerto Rico has a growing reputation as a biotech and pharmaceutical hub ('Bio Island') and plays host to manufacturing facilities from the world's largest pharmaceutical companies.

27 January 2008

Sanofi Pasteur Vaccine Production Plant, Swiftwater, Pennsylvania

Sanofi Pasteur, the vaccines business of Sanofi-Aventis, is one of the largest seasonal influenza vaccine producers in t

14 October 2007

Roche Bulk Active Ingredient Manufacturing Facility, Florence, SC

Roche Carolina is the highly successful US subsidiary of pharmaceutical giant Hoffmann La Roche. Roche has operated a pr

11 October 2007

Eli Lilly Biotech Pilot Plant, Indianapolis

In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re

29 November 2006

Lonza Biotec

Lonza Biotec completed the construction of new manufacturing capacity with a multi-product design at Visp in Switzerland

28 September 2003

Schering-Plough Production and R&D Facilities

Schering-Plough has continued to capitalise on its investment program into facilities based in Singapore. The company cu

21 September 2003

Indena Anti-Cancer Compound Plant Automation

Indena SpA, an Italian company based in Settala near Milan, has announced plans to automate its plant for the production

22 May 2003

Bristol-Myers Squibb’s Bulk Manufacturing Facility in Cruiserath, Ireland

In November 2000, Bristol-Myers Squibb began the construction of a new bulk manufacturing facility in the Republic of Ireland.

9 September 2001

Novartis’ API Plant in Grimsby, West Yorkshire, UK

Novartis Pharmaceuticals' active pharmaceutical ingredients (API) plant complex in Grimsby, West Yorkshire, was first established in 1951.

5 September 2001

Janssen Pharmaceutica’s Pharmaceutical Plant, Geel, Belgium

Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutica decided to build a new pharmaceutical plant in Geel in Belgium in 1998.

Glaxo Wellcome Anti-Infective Drugs Plant, Suzhou, China

In 1998, Glaxo Wellcome made an investment in a production facility in Suzhou in the eastern Chinese province of Jiangsu.

9 May 2001

Process Control Update at Cedarburg’s Intermediate and API Facility, Grafton, US

Cedarburg Pharmaceuticals awarded Emerson Process Management with a contract in 1998 to supply the company with process controls for its new facility in Grafton, Wisconsin, US.

AstraZeneca Pharmaceuticals Complex, Södartälje, Sweden

The project is a pharmaceuticals plant located at Snackviken, in Södartälje, Sweden. It is owned by AstraZeneca, which was formed by a merger of Swedish Astra and British Zeneca.

13 February 2001

AstraZeneca Large Scale Laboratory (LSL) Facility, Macclesfield, UK

AstraZeneca's large-scale laboratory (LSL) project was instigated as a brownfield development in Macclesfield, UK.

Press Release

5 August 2019

The 50th anniversary of the Apollo 11 moon landing draws near and ILC Dover’s ‘Beyond Boundaries™’ culture continues the bold innovation that put humans on the moon and brought them safely back to earth.

Read more
30 May 2019

The circumstances that gave birth to the biopharmaceutical industry are the same circumstances that present one of its key challenges: contamination.

Read more
23 May 2019

Member of the European Parliament (MEP) Deirdre Clune officially opened ILC Dover's new manufacturing facility in Blarney Business Park, Cork alongside ILC Dover CEO and President Fran DiNuzzo.

Read more
15 March 2019

ILC Dover has announced that it will be showcasing its containment solutions at Interphex. 

Read more
6 March 2019

ILC Dover has announced it will be showcasing its powder containment technologies at the 9th Annual Miami-Dade County Healthcare Preparedness Coalition Symposium.

Read more
2 November 2018

Flexible containment solutions provider ILC Dover is expanding its Irish production footprint by opening a location in Blarney, County Cork, Ireland.

Read more
9 April 2018

ILC Dover has announced that is will be attending the INTERPHEX tradeshow in New York, US. 

Read more
22 August 2017

ILC Dover has proven the efficacy of its new semi-automated system, which is designed to disaggregate powdered media and buffer powders for superior mixing into a solution.

Read more
14 March 2017

ILC Dover has successfully completed an Rx-360 pharmaceutical industry consortium audit for its packaging and supply chain security.

Read more
14 September 2015

ILC Dover has announced that it has acquired JetSolutions in Rossens, Switzerland.

Read more
4 July 2013

The new CrimpLoc system is the next generation to provide high containment, secure closure, and easy one-piece crimp removal without any breaking or risk of plastic shards.

Read more
17 April 2013

ILC Dover welcomes you to our exhibit at Powtech 2013. We will be located in hall 1 at booth 645 for the event in Nürnberg, Germany, which will take place 23-25 April 2013.

Read more
12 March 2013

LC Dover is committed to continuous improvement and listening to our customers. We first invented flexible high containment in 1997 and immediately improved the old standard of twist, tie, tape and cut for the separation of the flexible by inventing the crimp system.

Read more
19 September 2012

ILC Dover pioneered flexible containment for the pharmaceutical industry and continues to innovate processes for better performance. We invented the original crimping system and now we have created the CrimpLoc System.

Read more
30 August 2012

ILC Dover would like to invite you to attend the 2012 ISPE Conference in Brussels, Belgium, at the Thon Hotel Brussels EU, 17 to 18 September 2012. ILC Dover regional sales manager for Europe, Malcolm Cunningham, will be co-hosting this event and presenting a paper.

Read more
18 April 2012

As the leader in flexible containment, ILC Dover offers state-of-the-art containment technology.

Read more
17 October 2011

You are invited to visit ILC Dover at the 2011 CPHi Worldwide Show in Messe Frankfurt, Germany, on 25-27 October 2011.

Read more
11 October 2011

ILC Dover's NIOSH-approved Sentinel XL Clear™ Hood Powered Air Purifying Respirator (PAPR) is used in applications that are not using containment and where a combination of flexible containment and RPE support a process.

Read more
4 October 2011

You are invited to visit us at the 2011 Powtech Show in Nuremberg, Germany, on 11-13 October 2011.

Read more
27 July 2011

The ILC Dover weigh and dispense system is a new era in dispensing technology. This modular design has been developed to allow weighing or subdividing materials in a highly contained way while maintaining weighing accuracy. The system can be used for weighing and then directly charging

Read more
2 May 2011

Talk with the ILC Dover RPE and flexible containment experts about your industrial hygiene challenges at the annual AIHce show in Portland, OR, at the Oregon Convention Center, 16-18 May 2011, at booth 1647. On display you will see: Sentinel Clear™ Hood PAPR System Read more

8 March 2011

As the leader in flexible containment, we offer state-of-the-art containment technology. The DoverPac® films, designs and applications are accepted as the most cost-effective method to achieve high containment. See us at Interphex to discuss your applications and our proven solutions, expect

Read more
14 December 2010

The systems described here center around bin blending and V-Blender applications in oral solids dosage (OSD) manufacturing using flexible enclosures. Blending involves the controlled mixing of dry primary powder particles and excipients. The powders can range in properties and potency and, if not

Read more
14 December 2010

The systems described here center around bin blending and V-Blender applications in oral solids dosage (OSD) manufacturing using flexible enclosures. Blending involves the controlled mixing of dry primary powder particles and excipients. The powders can range in properties and potency and, if not

Read more
31 October 2010

Process area barrier curtains are a useful tool in improving the containment levels in existing installations as a method to reduce operational exposure risk and to restrict access. Examples of these types of applications include, but are not limited to, down flow booth curtains and room access b

Read more
7 October 2010

O'Hara Technologies will be displaying the DoverPac® flexible enclosure manufactured with clear ArmorFlex® film on their tablet coater at the 2010 AAPS Annual Meeting and Expo in New Orleans, US, at booth #1133.

Read more
16 September 2010

ILC Dover has announced that its DoverPac® SF family is advancing the state-of-the-art in buffer/media preparation for the biopharmaceutical industry with these single use, flexible systems. By using ILC's durable ArmorFlex® materials, 3D disposable vessels have been created

Read more
8 April 2010

ILC Dover's flexible powder containment technologies eliminate many of the problems associated with the use of traditional metal and glass systems for the pharmaceutical industry. To find out more about ILC Dover's flexible powder containment technologies visit the company at stand 303

Read more
17 November 2009

Particle size reduction is commonly required in pharmaceutical manufacturing. Taking into account today's need to mill highly hazardous compounds in conjunction with the need to minimize capital cost spending, the application of flexible containment to an existing Bohle BTS 100 sieve design demon

Read more
5 October 2009

Frederica, DE – ILC Dover has announced the introduction of a new permanent antistat contact film - ArmorFlex® 114. The rugged ArmorFlex family of films has been the recognized gold standard for materials of contact within the pharmaceutical industry since 1997. ILC

Read more
28 June 2009

Tray dryers are a common method of drying wetcakes and granulated drug products, especially in the early product development phase. The issue of containment for this type of process equipment is unique in that open scooping of powder on to multiple trays that get slotted into the dryer one at

Read more
6 May 2009

As the leader in flexible containment and disposable cGMP systems, ILC Dover, with the assistance of an independent third party consultant, has reviewed the products they offer to the pharmaceutical industry with regard to the REACH (Registration, Evaluation and Authorisation of Chemicals) regula

Read more
1 March 2009

Cutting edge flexible containment technologies are a proven solution to achieve containment for retrofit applications, and can be seen at ILC Dover’s stand (number 946) at Interphex in New York from 17 to 19 March 2009. Today’s marketplace and overall economy are putting more pressure t

Read more

Regional Offices

Coverage area: Europe


Daniel Leva +41 26 492 68 00
ILC Dover LP

One Moonwalker Road


DE 19946-2080

United States of America

+1 302 335 3911 +1 302 335 1320 Podcast on Flexible Containment in Pharmaceutical Industry

Go Top